Co-morbidities

View all - Anticoagulation Antiplatelet DOAC

View all - Demographic Gender Ethnicity

View all - Heterogeneous Populations Inherited and Congenital Cardiac Conditions Congenital Heart Disease

View all - Vascular Disease and Surgery Aortic Disease - General Aneurysm Carotid Artery Disease Stroke Peripheral Artery Disease - General Occlusive Venous Disease - General Deep Vascular Intervention Endovascular Techniques

View all - Standards & Guidelines

View all - Imaging & Diagnostics Angiography CT/MRI Echocardiography & Ultrasound Nuclear

View all - Heart Failure Amyloidosis Imaging and Diagnosis Devices Co-morbidities Cardiomyopathy Advancement in Heart Failure

View all - Electrophysiology & Arrhythmia Ventricular Arrhythmias Stroke Prevention in Atrial Fibrillation Pacing, Defibrillators & Cardiac Resynchronisation Therapy Catheter Ablation of Cardiac Arrhythmias Persistent Atrial Fibrillation Using Arctic Front™ Cardiac Cryoablation System Atrial Fibrillation Atrial Arrhythmias Sudden Cardiac Death

View all - Digital Health

View all - COVID-19

View all - Prevention & Chronic Conditions Cardiac Rehabilitation Programmes Chronic Kidney Disease Coronary Artery Disease and Myocardial Infarction Atherosclerosis and Hyperlipidemia Diabetes Hypertension Hypertension Management Pulmonary Arterial Hypertension Lifestyle Nonalcoholic Steatohepatitis (NASH) Obesity Stroke

View all - Pericardium Disorders

View all - MI/ACS Unstable Angina & NSTEMI STEMI

View all - Intervention Drug-eluting balloons Structural Intervention Peripheral Intervention Coronary Interventions Intravascular Imaging Coronary Physiology Bifurcation

View all - CV Disease in Special Populations Cardio-oncology

Most Recent Most Viewed

Topics

Article

Heart Failure

Growth Differentiation Factor-15 in Chronic Heart Failure

Yee Ling Cham , Alan Yean Yip Fong , Joshua Bui Kiong Chung , et al

Read time: 11 Mins

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Video

Vascular Disease and Surgery

Standards & Guidelines

View from the Thoraxcenter: ACC.23 Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Video

Heart Failure

Digital Health

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Video

Heart Failure

Prevention & Chronic Conditions

Radcliffe & CardioNerds @AHA22: The EMPA-Kidney Trial

Kate Wilcox, David Preiss,

Watch time: 18m 1s

Broadcast

Heart Failure

MI/ACS

Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Video

Heart Failure

EMPATROPISM FE: Effects of Empagliflozin on Iron Metabolism in Non-diabetic

Christiane Angermann,

Watch time: 22m 15s

Broadcast

Heart Failure

MI/ACS

Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Video

Heart Failure

EMPATROPISM FE: Effects of Empagliflozin on Iron Metabolism in Non-diabetic

Christiane Angermann,

Watch time: 22m 15s

Video

Heart Failure

Digital Health

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Video

Vascular Disease and Surgery

Standards & Guidelines

View from the Thoraxcenter: ACC.23 Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s

Video

Heart Failure

Prevention & Chronic Conditions

Radcliffe & CardioNerds @AHA22: The EMPA-Kidney Trial

Kate Wilcox, David Preiss,

Watch time: 18m 1s

Article

Heart Failure

Growth Differentiation Factor-15 in Chronic Heart Failure

Yee Ling Cham , Alan Yean Yip Fong , Joshua Bui Kiong Chung , et al

Read time: 11 Mins

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.